Open AccessFactors Influencing Treatment of Atypical Hemolytic Uremic Syndrome
Author(s) -
Carla Nester,
Richard J. Smith
Publication year - 2014
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.07540714
Subject(s) - atypical hemolytic uremic syndrome , medicine , eculizumab , population , immunology , disease , complement system , antibody , environmental health
Over the past 2 decades, tremendous strides have been made in our understanding of the ultra-rare disease atypical hemolytic uremic syndrome (aHUS). At the center of this progress has been the discovery that the majority of patients with aHUS (>50%) carry causative DNA variants in alternate
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom